Apple Watch Patent Dispute: Apple has restarted the sale of Watch Series 9 and Ultra 2 in some US stores, following an appeals court decision to temporarily lift the ban on these devices amid an ongoing patent dispute.
Wider Availability Soon
The availability of these watches is expected to expand to more Apple stores over the weekend, with online sales set to resume on Thursday (US time), according to reports from The Verge.
Appeals Court Decision
The appeals court has granted Apple permission to continue selling the watches temporarily. An Apple spokesperson expressed satisfaction with the decision, stating, “We are pleased the US Court of Appeals for the Federal Circuit has stayed the exclusion order while it considers our request to stay the order pending our full appeal.”
Apple’s Appeal to ITC Decision
Apple had appealed the International Trade Commission’s (ITC) ruling that led to the ban on sales of Watch Series 9 and Watch Ultra 2 models in the US. In court filings, Apple argued that the company would face “irreparable harm” if the latest watches remained unavailable for purchase during the legal proceedings.
Patent Dispute Background
The dispute between Apple and medical device maker Masimo revolves around the blood oxygen sensor (SpO2 sensor) technology used in the watches. The ITC had ruled in October that the blood oxygen sensor in Apple’s latest watches infringed on two Masimo patents.
What’s Next?
With sales resuming, Apple aims to navigate through the patent dispute while ensuring its flagship smartwatches remain accessible to customers. The decision by the appeals court provides a temporary relief for Apple in this ongoing legal battle.
ALSO READ | Reliance Jio plans ‘Bharat GPT’ AI model for India: Everything you need to know
ALSO READ | Why is NYT suing OpenAI and Microsoft for copyright infringement? Deets inside
Latest Technology News
Apple Watch Patent Dispute: Apple has restarted the sale of Watch Series 9 and Ultra 2 in some US stores, following an appeals court decision to temporarily lift the ban on these devices amid an ongoing patent dispute.
Wider Availability Soon
The availability of these watches is expected to expand to more Apple stores over the weekend, with online sales set to resume on Thursday (US time), according to reports from The Verge.
Appeals Court Decision
The appeals court has granted Apple permission to continue selling the watches temporarily. An Apple spokesperson expressed satisfaction with the decision, stating, “We are pleased the US Court of Appeals for the Federal Circuit has stayed the exclusion order while it considers our request to stay the order pending our full appeal.”
Apple’s Appeal to ITC Decision
Apple had appealed the International Trade Commission’s (ITC) ruling that led to the ban on sales of Watch Series 9 and Watch Ultra 2 models in the US. In court filings, Apple argued that the company would face “irreparable harm” if the latest watches remained unavailable for purchase during the legal proceedings.
Patent Dispute Background
The dispute between Apple and medical device maker Masimo revolves around the blood oxygen sensor (SpO2 sensor) technology used in the watches. The ITC had ruled in October that the blood oxygen sensor in Apple’s latest watches infringed on two Masimo patents.
What’s Next?
With sales resuming, Apple aims to navigate through the patent dispute while ensuring its flagship smartwatches remain accessible to customers. The decision by the appeals court provides a temporary relief for Apple in this ongoing legal battle.
ALSO READ | Reliance Jio plans ‘Bharat GPT’ AI model for India: Everything you need to know
ALSO READ | Why is NYT suing OpenAI and Microsoft for copyright infringement? Deets inside
Latest Technology News